Its unfortunate that these companies were selected in the first place. With or without duediligence ???? I can imagine any potential "funding" will be hesitant to commit. AE37 if successful will be the best bet, no crooks involved in the clinical trial. Any positive update will reflect in the NGIO pps , with or without revenue!! Lets get it listed and move forward!! Do we have the right Management team ......thats the question!!